186 related articles for article (PubMed ID: 16141330)
1. Deletion of XPC leads to lung tumors in mice and is associated with early events in human lung carcinogenesis.
Hollander MC; Philburn RT; Patterson AD; Velasco-Miguel S; Friedberg EC; Linnoila RI; Fornace AJ
Proc Natl Acad Sci U S A; 2005 Sep; 102(37):13200-5. PubMed ID: 16141330
[TBL] [Abstract][Full Text] [Related]
2. High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints.
Wistuba II; Behrens C; Virmani AK; Mele G; Milchgrub S; Girard L; Fondon JW; Garner HR; McKay B; Latif F; Lerman MI; Lam S; Gazdar AF; Minna JD
Cancer Res; 2000 Apr; 60(7):1949-60. PubMed ID: 10766185
[TBL] [Abstract][Full Text] [Related]
3. The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium.
Lerman MI; Minna JD
Cancer Res; 2000 Nov; 60(21):6116-33. PubMed ID: 11085536
[TBL] [Abstract][Full Text] [Related]
4. [Allelic losses on chromosomes 1p, 3p, 11p, 11q in non small cell lung cancers].
Cheng JQ; Crépin M; Hamelin R
C R Acad Sci III; 1990; 311(5):175-9. PubMed ID: 2169974
[TBL] [Abstract][Full Text] [Related]
5. Frequent allelic losses on chromosomes 2q, 18q, and 22q in advanced non-small cell lung carcinoma.
Shiseki M; Kohno T; Nishikawa R; Sameshima Y; Mizoguchi H; Yokota J
Cancer Res; 1994 Nov; 54(21):5643-8. PubMed ID: 7923210
[TBL] [Abstract][Full Text] [Related]
6. Neural tube development requires the cooperation of p53- and Gadd45a-associated pathways.
Patterson AD; Hildesheim J; Fornace AJ; Hollander MC
Birth Defects Res A Clin Mol Teratol; 2006 Feb; 76(2):129-32. PubMed ID: 16470852
[TBL] [Abstract][Full Text] [Related]
7. p53 dysfunction by xeroderma pigmentosum group C defects enhance lung adenocarcinoma metastasis via increased MMP1 expression.
Wu YH; Wu TC; Liao JW; Yeh KT; Chen CY; Lee H
Cancer Res; 2010 Dec; 70(24):10422-32. PubMed ID: 21056989
[TBL] [Abstract][Full Text] [Related]
8. Allelic deletion analysis of the FHIT gene predicts poor survival in non-small cell lung cancer.
Burke L; Khan MA; Freedman AN; Gemma A; Rusin M; Guinee DG; Bennett WP; Caporaso NE; Fleming MV; Travis WD; Colby TV; Trastek V; Pairolero PC; Tazelaar HD; Midthun DE; Liotta LA; Harris CC
Cancer Res; 1998 Jun; 58(12):2533-6. PubMed ID: 9635574
[TBL] [Abstract][Full Text] [Related]
9. RBM5/H37 tumor suppressor, located at the lung cancer hot spot 3p21.3, alters expression of genes involved in metastasis.
Oh JJ; Taschereau EO; Koegel AK; Ginther CL; Rotow JK; Isfahani KZ; Slamon DJ
Lung Cancer; 2010 Dec; 70(3):253-62. PubMed ID: 20338664
[TBL] [Abstract][Full Text] [Related]
10. Homozygous deletions at chromosome 9p21 and mutation analysis of p16 and p15 in microdissected primary non-small cell lung cancers.
Packenham JP; Taylor JA; White CM; Anna CH; Barrett JC; Devereux TR
Clin Cancer Res; 1995 Jul; 1(7):687-90. PubMed ID: 9816033
[TBL] [Abstract][Full Text] [Related]
11. Tobacco smoke-induced DNA damage and an early age of smoking initiation induce chromosome loss at 3p21 in lung cancer.
Hirao T; Nelson HH; Ashok TD; Wain JC; Mark EJ; Christiani DC; Wiencke JK; Kelsey KT
Cancer Res; 2001 Jan; 61(2):612-5. PubMed ID: 11212258
[TBL] [Abstract][Full Text] [Related]
12. Screening of homologous recombination gene polymorphisms in lung cancer patients reveals an association of the NBS1-185Gln variant and p53 gene mutations.
Medina PP; Ahrendt SA; Pollan M; Fernandez P; Sidransky D; Sanchez-Cespedes M
Cancer Epidemiol Biomarkers Prev; 2003 Aug; 12(8):699-704. PubMed ID: 12917199
[TBL] [Abstract][Full Text] [Related]
13. Reduced XPC messenger RNA level may predict a poor outcome of patients with nonsmall cell lung cancer.
Wu YH; Cheng YW; Chang JT; Wu TC; Chen CY; Lee H
Cancer; 2007 Jul; 110(1):215-23. PubMed ID: 17508409
[TBL] [Abstract][Full Text] [Related]
14. Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering.
Girard L; Zöchbauer-Müller S; Virmani AK; Gazdar AF; Minna JD
Cancer Res; 2000 Sep; 60(17):4894-906. PubMed ID: 10987304
[TBL] [Abstract][Full Text] [Related]
15. Three distinct regions involved in 3p deletion in human lung cancer.
Hibi K; Takahashi T; Yamakawa K; Ueda R; Sekido Y; Ariyoshi Y; Suyama M; Takagi H; Nakamura Y; Takahashi T
Oncogene; 1992 Mar; 7(3):445-9. PubMed ID: 1347916
[TBL] [Abstract][Full Text] [Related]
16. Frequent homozygous deletions in lung cancer cell lines detected by a DNA marker located at 3p21.3-p22.
Yamakawa K; Takahashi T; Horio Y; Murata Y; Takahashi E; Hibi K; Yokoyama S; Ueda R; Takahashi T; Nakamura Y
Oncogene; 1993 Feb; 8(2):327-30. PubMed ID: 8381220
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms in XPC, XPD, XRCC1, and XRCC3 DNA repair genes and lung cancer risk in a population of northern Spain.
López-Cima MF; González-Arriaga P; García-Castro L; Pascual T; Marrón MG; Puente XS; Tardón A
BMC Cancer; 2007 Aug; 7():162. PubMed ID: 17705814
[TBL] [Abstract][Full Text] [Related]
18. Sequential molecular abnormalities are involved in the multistage development of squamous cell lung carcinoma.
Wistuba II; Behrens C; Milchgrub S; Bryant D; Hung J; Minna JD; Gazdar AF
Oncogene; 1999 Jan; 18(3):643-50. PubMed ID: 9989814
[TBL] [Abstract][Full Text] [Related]
19. XPC mRNA level may predict relapse in never-smokers with non-small cell lung cancers.
Yeh KT; Wu YH; Lee MC; Wang L; Li CT; Chen CY; Lee H
Ann Surg Oncol; 2012 Mar; 19(3):734-42. PubMed ID: 21861227
[TBL] [Abstract][Full Text] [Related]
20. High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan.
Wang YC; Chen CY; Chen SK; Cherng SH; Ho WL; Lee H
Cancer Res; 1998 Jan; 58(2):328-33. PubMed ID: 9443413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
